Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 6/20 | 0.44 |
| ▸ | ANPEP | P15144 | 3/20 | 0.41 |
| ▸ | ENPEP | Q07075 | 3/20 | 0.41 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.38 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.38 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.38 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.37 |
| ▸ | KDM4A | O75164 | 2/20 | 0.37 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.37 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.37 |
| ▸ | TET3 | O43151 | 1/20 | 0.37 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mercaptopropionic Acid SCHEMBL22031777 | 1.00 | ACE (0.48) | ACELMNAALDH1A1FOLH1ANPEP | |
| Mercaptopropionic Acid SCHEMBL2227708 | 1.00 | ACE (0.48) | ACELMNAALDH1A1FOLH1ANPEP | |
| Mercaptopropionic Acid SCHEMBL538146 | 1.00 | ACE (0.48) | ACELMNAALDH1A1FOLH1ANPEP | |
| Mercaptopropionic Acid SCHEMBL15379303 | 1.00 | ACE (0.48) | ACELMNAALDH1A1FOLH1ANPEP | |
| Mercaptopropionic Acid SCHEMBL331013 | 0.91 | LMNA (0.59) | ACELMNAALDH1A1FOLH1ANPEP | |
| Glycerin SCHEMBL4958002 | 0.86 | FOLH1 (0.58) | LMNAALDH1A1FOLH1ENPEPSLC22A6 | |
| E968 SCHEMBL2761775 | 0.85 | ACE (0.48) | ACELMNAFOLH1ANPEPENPEP | |
| E968 SCHEMBL30719377 | 0.85 | ACE (0.48) | ACELMNAFOLH1ANPEPENPEP | |
| E968 SCHEMBL10708699 | 0.85 | ACE (0.48) | ACELMNAFOLH1ANPEPENPEP | |
| Mercaptopropionic Acid SCHEMBL10002581 | 0.84 | SLC22A6 (0.37) | ACELMNAALDH1A1FOLH1ANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 235 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2921511-B1 | POLYMERIZABLE COMPOSITION, OPTICAL MATERIAL AND MANUFACTURING METHOD FOR SAME | MITSUI CHEMICALS INC (JP) | 2017-11-01 | — | — | EP | claimed |
| US-9778397-B2 | Polymerizable composition, optical material, and manufacturing method of the same | MITSUI CHEMICALS, INC. (JP) | 2017-10-03 | — | — | US | claimed |
| US-20150331147-A1 | POLYMERIZABLE COMPOSITION, OPTICAL MATERIAL, AND MANUFACTURING METHOD OF THE SAME | MITSUI CHEMICALS, INC. (JP) | 2015-11-19 | — | — | US | claimed |
| US-8445615-B2 | Two-component adhesive suitable for construction purposes, its use and the cured structural bonds obtained thereby | HILTI AKTIENGESELLSCHAFT (LI) | 2013-05-21 | — | — | US | claimed |
| US-8344059-B2 | Two-component mortar composition suitable for construction purposes, its use and the cured structural objects obtained thereby | HILTI AKTIENGESELLSCHAFT (LI) | 2013-01-01 | — | — | US | claimed |
| EP-2336214-B1 | A two-component adhesive suitable for construction purposes, its use and the cured structural bonds obtained thereby | HILTI AG (LI) | 2012-05-02 | — | — | EP | claimed |
| EP-2327731-B1 | A two-component mortar composition suitable for construction purposes, its use and the cured structural objects obtained thereby | HILTI AG (LI) | 2012-04-25 | — | — | EP | claimed |
| EP-2336214-A1 | A two-component adhesive suitable for construction purposes, its use and the cured structural bonds obtained thereby | HILTI Aktiengesellschaft (LI) | 2011-06-22 | — | — | EP | claimed |
| US-20110143061-A1 | TWO-COMPONENT ADHESIVE SUITABLE FOR CONSTRUCTION PURPOSES, ITS USE AND THE CURED STRUCTURAL BONDS OBTAINED THEREBY | HILTI AKTIENGESELLSCHAFT (LI) | 2011-06-16 | — | — | US | claimed |
| US-20110136942-A1 | TWO-COMPONENT MORTAR COMPOSITION SUITABLE FOR CONSTRUCTION PURPOSES, ITS USE AND THE CURED STRUCTURAL OBJECTS OBTAINED THEREBY | HILTI AKTIENGESELLSCHAFT (LI) | 2011-06-09 | — | — | US | claimed |
| EP-2327731-A1 | A two-component mortar composition suitable for construction purposes, its use and the cured structural objects obtained thereby | HILTI Aktiengesellschaft (LI) | 2011-06-01 | — | — | EP | claimed |
| US-12625430-B2 | Colored photosensitive resin composition and mutilayer cured film prepared therefrom | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2026-05-12 | — | — | US | disclosed |
| US-12570864-B2 | Storage-stable pigmented formulations containing isocyanate groups and use thereof | COVESTRO DEUTSCHLAND AG (DE) | 2026-03-10 | — | — | US | disclosed |
| US-20250382514-A1 | CURABLE ADHESIVE COMPOSITION COMPRISING MALEIMIDE AND THIOL | HENKEL AG & CO KGAA (DE) | 2025-12-18 | — | — | US | disclosed |
| US-12501540-B2 | Electronic device and manufacturing method thereof | FUJIFILM CORPORATION (JP) | 2025-12-16 | — | — | US | disclosed |
| WO-2006077144-A1 | COPOLYMERS FOR COSMETIC AGENTS, PRODUCED IN THE PRESENCE OF POLYFUNCTIONAL CHAIN TRANSFER AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 2006-07-27 | — | — | WO | disclosed |
| WO-2005100436-A1 | RADICALLY CURABLE RESIN COMPOSITIONS | DSM IP ASSETS B.V. (NL) | 2005-10-27 | — | — | WO | disclosed |
| EP-1586596-A1 | Radically curable resin compositions | DSM IP Assets B.V. (NL) | 2005-10-19 | — | — | EP | disclosed |
| EP-0270709-B1 | PROCESS FOR THE PRODUCTION OF VINYL POLYMERS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-02-06 | — | — | EP | disclosed |
| EP-0270709-A1 | Process for the production of vinyl polymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-06-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12625430-B2 | Colored photosensitive resin composition and mutilayer cured film prepared therefrom | RAD51, SMURF1, SMARCA1 | ACE 4688/4885LMNA 2616/4885ALDH1A1 1348/4885 |
| US-12570864-B2 | Storage-stable pigmented formulations containing isocyanate groups and use thereof | RB1, ALDH1A2, IDH3A | ACE 4806/4885LMNA 883/4885ALDH1A1 433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.